Mr Michal Ugarenko
Research Assistant
Department of Biochemistry and Pharmacology
10 Scholarly works
0 Projects
HIGHLIGHTS
2020
Journal article
DOT1L-controlled cell-fate determination and transcription elongation are independent of H3K79 methylation
DOI: 10.1073/pnas.20010751172020
Journal article
Abstract B46: CATACOMB: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb Repressive complex 2 via a H3K27M-like mechanism
DOI: 10.1158/1538-7445.pedca19-b462020
Journal article
Coordinated regulation of cellular identity–associated H3K4me3 breadth by the COMPASS family
DOI: 10.1126/sciadv.aaz47642020
Journal article
Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation
DOI: 10.1038/s41588-020-0618-12019
Journal article
Catacomb: An endogenous inducible gene that antagonizes H3K27 methylation activity of Polycomb repressive complex 2 via an H3K27M-like mechanism
DOI: 10.1126/sciadv.aax28872017
Journal article
PAF1 regulation of promoter-proximal pause release via enhancer activation
DOI: 10.1126/science.aan32692015
Journal article
Potential therapeutic advantages of doxorubicin when activated by formaldehyde to function as a dna adduct-forming agent
DOI: 10.2174/1568026615666150413154512
RECENT SCHOLARLY WORKS
2011
Journal article
Abstract A29: Bcl-2 overexpression provides short-term resistance to doxorubicin-DNA adducts but does not protect against longer-term treatments in HL-60 cells.
DOI: 10.1158/1535-7163.targ-11-a292010
Journal article
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts
DOI: 10.1016/j.bcp.2009.09.0042009
Journal article
Development of pluronic micelle-encapsulated doxorubicin and formaldehyde-releasing prodrugs for localized anticancer chemotherapy
DOI: 10.3727/096504009787721212